Drugs / DTaP IPV//Hib vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01411241 | Jul 2011 → Feb 2014 | Dengue hemorrhagic fever | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DTaP IPV//Hib vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01411241 ↗ |
| Modality | Vaccine | “pediatric combination vaccine (Pentaxim™)” NCT01411241 ↗ |
| Route | Intramuscular | “0.5 mL, intramuscular” NCT01411241 ↗ |